SCHEMBL6193003

SCHEMBL6193003

Brc1ccc2c(c1)-c1nc(-c3ccccc3)sc1CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
HPGD P15428 3/20 0.44
ADORA1 P30542 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 4/20 0.43
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GLA P06280 2/20 0.43
USP2 O75604 1/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
FBP1 P09467 4/20 0.42
TP53 P04637 1/20 0.41
MPI P34949 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30216205 0.72 L3MBTL1 (0.43) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL29191896 0.72 L3MBTL1 (0.43) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL12797297 0.70 FBP1 (0.63) ALDH1A1ADORA1MAPTKDM4EFBP1
SCHEMBL15174607 0.70 MAPT (0.46) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL598138 0.67 TDP1 (0.61) L3MBTL1TDP1
SCHEMBL15174702 0.67 ADORA1 (0.63) ALDH1A1ADORA1MAPTKDM4EFBP1
SCHEMBL595453 0.65 KDM4E (0.57) ALDH1A1MEN1KMT2AL3MBTL1HPGD
SCHEMBL30903625 0.65 APP (0.71) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL15414023 0.65 APP (0.71) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL31390879 0.65 ADORA1 (0.67) ALDH1A1ADORA1MAPTKDM4EFBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183247-B1 POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS AVENTIS PHARMA GMBH (DE) 2005-05-25 EP disclosed
EP-1156805-B1 USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR MANUFACTURING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY AVENTIS PHARMA GMBH (DE) 2004-08-11 EP disclosed
EP-1183247-A1 POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
US-6329407-B1 ANOREXOGENIC AGENTS AVENTISPHARMA DEUTSCHLAND GMBH (DE) 2001-12-11 US disclosed
EP-1156805-A2 USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY Aventis Pharma Deutschland GmbH (DE) 2001-11-28 EP disclosed
US-6187801-B1 6-CHLORO-2-METHYL-8H-INDENO(1,2-D)-THIAZOLE HYDROCHLORIDE, FOR EXAMPLE; ADMINISTERING TO TREAT OBESITY, DIABETES; ANORECTICS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-02-13 US disclosed
WO-2000051579-A2 USE OF POLYCYCLIC THIAZOLE SYSTEMS FOR PRODUCING MEDICAMENTS FOR PREVENTING OR TREATING OBESITY AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed
WO-2000051997-A1 POLYCYCLIC THIAZOLE SYSTEMS AND THEIR UTILIZATION AS ANORECTICS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed